Competitive ThreatsCME now faces a 3-front battle with BGC Partners (BGC), Cboe Global Markets (CBOE) and Intercontinental Exchange (ICE).
Market PerformanceCME shares trading at approximately 10% discount to peers, versus historical 20% premium, and the shares up just 4% year-to-date, underperforming peers by 17 percentage points given competitive concerns with recent FMX launch and market concerns around the outlook for volume growth.
Volume Growth OutlookAnalyst reiterates an underperform rating due to expected decline in volatility, which may slow CME's volume growth in most asset classes.